Aloe vera supplementation improves cardiovascular risk factors in hemodialysis patients: A randomized, double-blind, placebo-controlled trial

Objective: This study assessed the effects of Aloe verasupplementation on serum inflammatory factors, blood sugar andlipid profiles in hemodialysis patients.Materials and Methods: Totally, ۵۰ hemodialysis patients wereallocated randomly to either Aloe vera or placebo groups. TheAloe vera group received ۲ Aloe vera capsules daily for ۸ weeks(۵۰۰ mg/day). Serum C-reactive protein (hs- CRP), Fasting bloodglucose (FBS), and lipid profiles levels were evaluated at thebaseline and the end of the eighth week.Results: Aloe vera supplementation for ۸ weeks was associatedwith a significant reduction of serum hs- CRP (p=۰.۰۰۴), totalcholesterol (p=۰.۰۱), low density lipoprotein (LDL) (p=۰.۰۲) levesand increased high density lipoprotein (HDL) (p=۰.۰۰۲)concentration in the hemodialysis patients.Conclusion: Aloe vera supplementation is beneficial inimprovement of cardiovascular risk factors in hemodialysispatients

کلیدواژه ها:

Aloe vera ، C-reactive protein ، Inflammation ، Lipids ، hemodialysis